- Home
- MOLN vs SJT Comparison
MOLN vs SJT Comparison
Compare MOLN & SJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | MOLN | SJT |
|---|---|---|
| Founded | 2004 | 1980 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | | Oil & Gas Production |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.2M | 268.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | MOLN | SJT |
|---|---|---|
| Price | $4.23 | $5.75 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.75 | N/A |
| AVG Volume (30 Days) | 3.9K | ★ 185.4K |
| Earning Date | 02-11-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $24,557.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $999.99 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.36 | $3.77 |
| 52 Week High | $5.91 | $7.22 |
Technical Indicators
Market Signals| Indicator | MOLN | SJT |
|---|---|---|
| Relative Strength Index (RSI) | 48.68 | 53.96 |
| Support Level | $4.21 | $5.24 |
| Resistance Level | $4.38 | $5.81 |
| Average True Range (ATR) | 0.15 | 0.22 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 40.32 | 89.47 |
Price Performance
Historical ComparisonAbout MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About SJT San Juan Basin Royalty Trust
San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.